Claims That Cardiac Device Grows New Arteries Earn Devicemaker FDA Warning Letter

Marketing its cardiac device — intended to treat chronic angina — for un-cleared uses such as growth of new arteries, reduction of COVID-19 symptoms, regeneration of pancreatic tissue, and hair growth has earned Soulaire, a Santa Monica, Calif., devicemaker, an FDA Warning Letter.
Source: Drug Industry Daily